| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Issuance( Retirement)of Debt Net | -10.55 | 6.01 | -4.18 | -14.17 |
| Net Changein Cash | -19.53 | 17.33 | -170.94 | 75.44 |
| Cash Taxes Paid | 59.67 | 49.23 | 36.64 | 54.53 |
| Net Income/ Starting Line | 187.36 | 187.82 | 140.39 | 171.06 |
| Total Cash Dividends Paid | -59.03 | -56.71 | -12.54 | -11.86 |
| Changesin Working Capital | -71.90 | -75.49 | -36.96 | -81.93 |
| Cashfrom Operating Activities | 142.50 | 141.37 | 140.38 | 122.29 |
| Cash Interest Paid | 3.34 | 2.93 | 2.42 | 1.78 |
| Cashfrom Financing Activities | -72.54 | -59.24 | -25.80 | -48.50 |
| Issuance( Retirement)of Stock Net | 0.38 | 0.00 | 0.14 | 0.43 |
| Depreciation/ Depletion | 36.56 | 35.24 | 35.03 | 34.98 |
| Other Investing Cash Flow Items Total | -55.29 | -22.34 | -260.08 | 24.33 |
| Capital Expenditures | -33.81 | -42.31 | -38.11 | -28.12 |
| period Type | - | - | - | - |
| Foreign Exchange Effects | -0.38 | -0.15 | 12.66 | 5.43 |
| Non- Cash Items | -9.52 | -6.21 | 1.93 | -1.82 |
| Financing Cash Flow Items | -3.34 | -8.53 | -9.22 | -22.90 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -89.10 | -64.65 | -298.18 | -3.79 |
Advanced Enzyme Technologies Dividend Advanced Enzyme Technologies Bonus Advanced Enzyme Technologies News Advanced Enzyme Technologies AGM Advanced Enzyme Technologies Rights Advanced Enzyme Technologies Splits Advanced Enzyme Technologies Board Meetings Advanced Enzyme Technologies Key Metrics Advanced Enzyme Technologies Shareholdings Advanced Enzyme Technologies Profit Loss Advanced Enzyme Technologies Balance Sheet Advanced Enzyme Technologies Q1 Results Advanced Enzyme Technologies Q2 Results Advanced Enzyme Technologies Q3 Results Advanced Enzyme Technologies Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks